Literature DB >> 19224191

[Classification of gastro-entero-pancreatic neuroendocrine tumors].

A Perren1, A Schmitt, P Komminoth, M Pavel.   

Abstract

Tumors of the disseminated/diffuse neuroendocrine system (NET) are characterized by a common phenotype. However, the biology varies according to histomorphology, endocrine symptoms and organ of origin. The WHO classification takes these differences into account and uses a common framework, where the parameters size and extent of invasion vary according to the organ of origin. In order to achieve a further standardization of reporting the European Neuroendocrine Tumor Society (ENETS) recently proposed a tumor-node-metastasis (TNM) staging and grading system for gastro-entero-pancreatic NET.

Entities:  

Mesh:

Year:  2009        PMID: 19224191     DOI: 10.1007/s00117-008-1781-z

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  21 in total

1.  Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas).

Authors:  Robert T Jensen; Guido Rindi; Rudolf Arnold; José M Lopes; Maria Luisa Brandi; Wolf O Bechstein; Emanuel Christ; Babs G Taal; Ulrich Knigge; Hakan Ahlman; Dik J Kwekkeboom; Dermot O'Toole
Journal:  Neuroendocrinology       Date:  2007-02-20       Impact factor: 4.914

2.  Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases.

Authors:  W Kimura; A Kuroda; Y Morioka
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 3.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Epidemiology of pancreatic cancer in Connecticut.

Authors:  R E Moldow; R R Connelly
Journal:  Gastroenterology       Date:  1968-12       Impact factor: 22.682

5.  Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

6.  ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis.

Authors:  G Rindi; C Azzoni; S La Rosa; C Klersy; D Paolotti; S Rappel; M Stolte; C Capella; C Bordi; E Solcia
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

Review 7.  Carcinoid tumors of the gut. Our experience over three decades and review of the literature.

Authors:  J B Marshall; G Bodnarchuk
Journal:  J Clin Gastroenterol       Date:  1993-03       Impact factor: 3.062

8.  Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material.

Authors:  L Grimelius; G T Hultquist; B Stenkvist
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

9.  Insulinoma: clinical and diagnostic features of 60 consecutive cases.

Authors:  F J Service; A J Dale; L R Elveback; N S Jiang
Journal:  Mayo Clin Proc       Date:  1976-07       Impact factor: 7.616

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  2 in total

1.  [Gastroenteropancreatic endocrine tumors].

Authors:  C Schmid-Tannwald; C M Schmid-Tannwald; M F Reiser; F Berger
Journal:  Radiologe       Date:  2014-10       Impact factor: 0.635

2.  Hindgut gastropancreatic neuroendocrine carcinoma mimicking hydatid disease.

Authors:  Azza A Elgendy; William MacDonald; Joseph Whitnah; Daniel Malone; Brandon Johnson; Nadia Huq
Journal:  Radiol Case Rep       Date:  2017-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.